Xue‐Qun Luo

2.4k total citations
59 papers, 1.5k citations indexed

About

Xue‐Qun Luo is a scholar working on Molecular Biology, Cancer Research and Hematology. According to data from OpenAlex, Xue‐Qun Luo has authored 59 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Molecular Biology, 18 papers in Cancer Research and 15 papers in Hematology. Recurrent topics in Xue‐Qun Luo's work include Cancer-related molecular mechanisms research (13 papers), Acute Myeloid Leukemia Research (12 papers) and Retinoids in leukemia and cellular processes (11 papers). Xue‐Qun Luo is often cited by papers focused on Cancer-related molecular mechanisms research (13 papers), Acute Myeloid Leukemia Research (12 papers) and Retinoids in leukemia and cellular processes (11 papers). Xue‐Qun Luo collaborates with scholars based in China, Hong Kong and Australia. Xue‐Qun Luo's co-authors include Yujie Chen, Wei Huang, Wentao Wang, Ke Fang, Yumeng Sun, Libin Huang, Hua Zhang, Zhan‐Cheng Zeng, Lin-Yu Sun and Cai Han and has published in prestigious journals such as Blood, Molecular Cell and PLoS ONE.

In The Last Decade

Xue‐Qun Luo

52 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Xue‐Qun Luo China	21	1.2k	881	202	119	116	59	1.5k
Chao Shen China	14	779 0.7×	550 0.6×	90 0.4×	89 0.7×	93 0.8×	33	1.0k
Kwan Yeung Wong Hong Kong	23	1.0k 0.9×	812 0.9×	276 1.4×	151 1.3×	81 0.7×	37	1.4k
Chengwu Zeng China	22	1.6k 1.4×	1.2k 1.3×	170 0.8×	323 2.7×	132 1.1×	60	2.1k
Charles F. Spurlock United States	16	509 0.4×	517 0.6×	79 0.4×	80 0.7×	112 1.0×	26	971
Xiulan Yang United States	14	442 0.4×	379 0.4×	90 0.4×	260 2.2×	55 0.5×	25	861
Jared Wallace United States	14	557 0.5×	336 0.4×	119 0.6×	76 0.6×	66 0.6×	17	902
Xiuping Liu China	12	1.2k 1.0×	1.0k 1.2×	46 0.2×	188 1.6×	54 0.5×	24	1.5k
Houda Alachkar United States	20	613 0.5×	156 0.2×	190 0.9×	192 1.6×	50 0.4×	60	1.0k
Haimeng Yan China	12	541 0.5×	230 0.3×	112 0.6×	183 1.5×	92 0.8×	25	944
Jie Shi China	13	366 0.3×	300 0.3×	73 0.4×	127 1.1×	44 0.4×	48	644

Countries citing papers authored by Xue‐Qun Luo

Since Specialization

Citations

This map shows the geographic impact of Xue‐Qun Luo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xue‐Qun Luo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xue‐Qun Luo more than expected).

Fields of papers citing papers by Xue‐Qun Luo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xue‐Qun Luo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xue‐Qun Luo. The network helps show where Xue‐Qun Luo may publish in the future.

Co-authorship network of co-authors of Xue‐Qun Luo

This figure shows the co-authorship network connecting the top 25 collaborators of Xue‐Qun Luo. A scholar is included among the top collaborators of Xue‐Qun Luo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xue‐Qun Luo. Xue‐Qun Luo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Li, Xiang, Xue‐Qun Luo, Wenjun Wang, et al.. (2025). Sirtuins in Parkinson's disease: Molecular mechanisms and pathophysiological roles. Ageing Research Reviews. 112. 102902–102902.

Song, Zichen, Xi Sun, Yingli Liu, et al.. (2025). Arsenic trioxide-induced pyroptosis promotes the release of HMGB1 to activate natural killer cells related immunogenic cell death in leukemia. Chinese Chemical Letters. 111585–111585. 1 indexed citations

Li, Ao, Xue‐Qun Luo, Jiafeng Wang, et al.. (2025). The influence of climate change on Primula Sect. Crystallophlomis in southwest China. BMC Plant Biology. 25(1). 438–438.

Han, Juan, Fen Zhou, Runming Jin, et al.. (2024). The Efficacy and Safety of Huaiqihuang Granules in the Treatment of Childhood Chronic Primary Immune Thrombocytopenia: A Multicentre, Randomized, Double-Blind, Placebo-Controlled Clinical Study. Blood. 144(Supplement 1). 5461–5461.

Wang, Lina, Li Yu, Cong Liang, et al.. (2024). The Potential Transcriptomic and Metabolomic Mechanisms of ATO and ATRA in Treatment of FLT3-ITD Acute Myeloid Leukemia. Technology in Cancer Research & Treatment. 23. 2223964968–2223964968. 2 indexed citations

Li, Jianan, Yu Li, Lina Wang, et al.. (2023). Case Report: CD19 and CD20 monoclonal antibodies with sequential chemotherapy for refractory acute B-lymphocytic leukemia in children. Frontiers in Immunology. 14. 1280759–1280759.

Chen, Jun-zhu, Lina Wang, Xue‐Qun Luo, & Yan‐Lai Tang. (2023). The genomic landscape of sensitivity to arsenic trioxide uncovered by genome-wide CRISPR-Cas9 screening. Frontiers in Oncology. 13. 1178686–1178686. 1 indexed citations

Qin, Le, Jiang Lv, Di Wu, et al.. (2023). The onco-embryonic antigen ROR1 is a target of chimeric antigen T cells for colorectal cancer. International Immunopharmacology. 121. 110402–110402. 7 indexed citations

Massudi, Hassina, Jessica K. Holien, Jessica Koach, et al.. (2023). Inhibitors of the Oncogenic PA2G4-MYCN Protein-Protein Interface. Cancers. 15(6). 1822–1822.

10.

Liu, Yingli, Xiaoli Zhang, Yan‐Lai Tang, et al.. (2022). Combination of C-Reactive Protein and Procalcitonin in Distinguishing Fungal from Bacterial Infections Early in Immunocompromised Children. Antibiotics. 11(6). 730–730. 5 indexed citations

11.

Huang, Wei, Yumeng Sun, Qi Pan, et al.. (2022). The snoRNA-like lncRNA LNC-SNO49AB drives leukemia by activating the RNA-editing enzyme ADAR1. Cell Discovery. 8(1). 117–117. 30 indexed citations

12.

Zhang, Lidan, Yuhui Wu, Huimin Huang, et al.. (2021). Performance of PRISM III, PELOD-2, and P-MODS Scores in Two Pediatric Intensive Care Units in China. Frontiers in Pediatrics. 9. 626165–626165. 8 indexed citations

13.

Tang, Wenyan, Yanhua Zhang, Yao Liao, et al.. (2021). Abnormal thymic B cell activation and impaired T cell differentiation in pristane-induced lupus mice. Immunology Letters. 231. 49–60. 6 indexed citations

14.

Sun, Lin-Yu, Wentao Wang, Cai Han, et al.. (2021). The oncomicropeptide APPLE promotes hematopoietic malignancy by enhancing translation initiation. Molecular Cell. 81(21). 4493–4508.e9. 81 indexed citations

15.

Liang, Cong, Li Yu, Lina Wang, et al.. (2020). Up-regulated miR-155 is associated with poor prognosis in childhood acute lymphoblastic leukemia and promotes cell proliferation targeting ZNF238. Hematology. 26(1). 16–25. 17 indexed citations

16.

Wang, Wentao, Cai Han, Zhenhua Chen, et al.. (2019). Activation of the Lysosome-Associated Membrane Protein LAMP5 by DOT1L Serves as a Bodyguard for MLL Fusion Oncoproteins to Evade Degradation in Leukemia. Clinical Cancer Research. 25(9). 2795–2808. 35 indexed citations

17.

Sun, Yumeng, Wentao Wang, Zhan‐Cheng Zeng, et al.. (2019). circMYBL2, a circRNA from MYBL2, regulates FLT3 translation by recruiting PTBP1 to promote FLT3-ITD AML progression. Blood. 134(18). 1533–1546. 167 indexed citations

18.

Chen, Zhenhua, Wentao Wang, Wei Huang, et al.. (2016). The lncRNA HOTAIRM1 regulates the degradation of PML-RARA oncoprotein and myeloid cell differentiation by enhancing the autophagy pathway. Cell Death and Differentiation. 24(2). 212–224. 175 indexed citations

19.

Huang, Li‐Bin, et al.. (2009). Current status of diagnosis and prognosis of infant acute leukemia in China. Pediatric Blood & Cancer. 53(6). 973–977. 3 indexed citations

20.

Luo, Xue‐Qun, et al.. (2008). Maintenance therapy with dose‐adjusted 6‐mercaptopurine in idiopathic pulmonary hemosiderosis. Pediatric Pulmonology. 43(11). 1067–1071. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact